由于货币条件有利,West Pharmicals Services提高了2024年经调整的EPS预期值和净销售指导。 West Pharmaceutical Services raises 2024 adjusted EPS expectations and net sales guidance due to favorable currency conditions.

西方制药服务公司 (WST) 更新了其2024年的预测,调整后的每股收益预期提高到6.55美元至6.75美元,净销售预期为2875亿美元至2905亿美元,受有利的货币条件的影响. West Pharmaceutical Services, Inc. (WST) has updated its 2024 guidance, raising adjusted EPS expectations to $6.55-$6.75 and net sales guidance to $2.875-$2.905 billion, influenced by favorable currency conditions. 在第三季度,该公司报告利为1.36亿美元 (每股1.85美元),超过预期的1.50美元,尽管收入下降了0.1%,达到7.46亿美元. In Q3, the company reported a profit of $136 million ($1.85 per share), surpassing expectations of $1.50, despite a 0.1% revenue decline to $746.9 million. 执行局核准第四季度红利增加5%,达到每股0.21美元。 The Board approved a 5% increase in the fourth-quarter dividend to $0.21 per share.